Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revision hip replacement acetabular impaction grafting comparison
2006-001725-25Phase 4Terminated
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jul 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of bone morphogenetic protein 7 in acetabular bone deficiency (3 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Radiostereometric assessment of hip replacement stability/support. Started Jul 2007; status: terminated.
02
Drugs
bone morphogenetic protein 7
03
Conditions
acetabular bone deficiency
Beyond the preview
Go deeper on 2006-001725-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001725-25.